Genelux (GNLX) Enterprise Value (2022 - 2026)

Genelux's (GNLX) quarterly Enterprise Value came in at -$9.3 million in Q1 2026, up 32.8% year-on-year from -$7.0 million in Q1 2025, and up 24.09% quarter-over-quarter from -$12.2 million in Q4 2025.

Genelux (GNLX) Enterprise Value (2022 - 2026) Analysis & Trends

Genelux's Enterprise Value history runs 5 years deep, the most recent figure standing at -$9.3 million for Q1 2026.

  • On a quarterly basis, Enterprise Value rose 32.8% year-over-year to -$9.3 million in Q1 2026; TTM through Mar 2026 was -$9.3 million, a 32.8% increase from a year earlier, with the FY2025 full-year figure at -$12.2 million, up 60.46% from the prior year.
  • Enterprise Value advanced to -$9.3 million in Q1 2026 per GNLX's latest filing, from -$12.2 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$397000.0 in Q4 2022 and bottomed at -$66.2 million in Q2 2024.
  • The 5-year median for Enterprise Value is -$25.8 million (2023), against an average of -$29.2 million.
  • Across the five-year window, Enterprise Value slumped 5365.24% in 2023 and surged 66.52% in 2025, its largest moves.
  • Year by year, Enterprise Value stood at -$397000.0 in 2022, then slumped by 5365.24% to -$21.7 million in 2023, then tumbled by 42.39% to -$30.9 million in 2024, then jumped by 60.46% to -$12.2 million in 2025, then climbed by 24.09% to -$9.3 million in 2026.
  • Per Business Quant, the three latest GNLX Enterprise Value figures stand at -$9.3 million (Q1 2026), -$12.2 million (Q4 2025), and -$20.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -2.83 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -1.91 Bn
10 Genelux 129.36 Mn 129.36 Mn - -9.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.27 Mn
Dec 31, 2025 -12.22 Mn
Sep 30, 2025 -20.90 Mn
Jun 30, 2025 -47.65 Mn
Mar 31, 2025 -13.80 Mn
Dec 31, 2024 -30.90 Mn
Sep 30, 2024 -62.42 Mn
Jun 30, 2024 -66.23 Mn
Mar 31, 2024 -35.19 Mn
Dec 31, 2023 -21.70 Mn
Sep 30, 2023 -29.87 Mn
Dec 31, 2022 -397,000.00